653 related articles for article (PubMed ID: 9212111)
1. Identification of tissue transglutaminase as the autoantigen of celiac disease.
Dieterich W; Ehnis T; Bauer M; Donner P; Volta U; Riecken EO; Schuppan D
Nat Med; 1997 Jul; 3(7):797-801. PubMed ID: 9212111
[TBL] [Abstract][Full Text] [Related]
2. Tissue transglutaminase antibodies in celiac disease, comparison of an enzyme linked immunosorbent assay and a dot blot assay.
Mankaï A; Sakly W; Landolsi H; Gueddah L; Sriha B; Ayadi A; Sfar MT; Skandrani K; Harbi A; Essoussi AS; Korbi S; Fabien N; Jeddi M; Ghedira I
Pathol Biol (Paris); 2005 May; 53(4):204-9. PubMed ID: 15850953
[TBL] [Abstract][Full Text] [Related]
3. Serology of celiac disease in gluten-sensitive ataxia or neuropathy: role of deamidated gliadin antibody.
Rashtak S; Rashtak S; Snyder MR; Pittock SJ; Wu TT; Gandhi MJ; Murray JA
J Neuroimmunol; 2011 Jan; 230(1-2):130-4. PubMed ID: 21056914
[TBL] [Abstract][Full Text] [Related]
4. Transglutaminase, gluten and celiac disease: food for thought. Transglutaminase is identified as the autoantigen of celiac disease.
Marsh MN
Nat Med; 1997 Jul; 3(7):725-6. PubMed ID: 9212095
[No Abstract] [Full Text] [Related]
5. Interpretation of serological tests in the diagnosis of celiac disease: Anti-deamidated gliadin peptide antibodies revisited.
Zucchini L; Giusti D; Gatouillat G; Servettaz A; Tabary T; Barbe C; Pham BN
Autoimmunity; 2016 Sep; 49(6):414-420. PubMed ID: 27452003
[TBL] [Abstract][Full Text] [Related]
6. Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.
Stenman SM; Lindfors K; Korponay-Szabo IR; Lohi O; Saavalainen P; Partanen J; Haimila K; Wieser H; Mäki M; Kaukinen K
BMC Immunol; 2008 Feb; 9():6. PubMed ID: 18312620
[TBL] [Abstract][Full Text] [Related]
7. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
Lindfors K; Mäki M; Kaukinen K
Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
[TBL] [Abstract][Full Text] [Related]
8. [Relevance of anti-tissue transglutaminase antibodies in coeliac disease diagnosis].
Lepers S; Soula F; Fily S; Fontaine E; Vuye S; Colombel JF; Guimber D; Prin L; Dubucquoi S
Ann Biol Clin (Paris); 2003; 61(3):337-43. PubMed ID: 12805013
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of deamidated gliadin peptide antibody in celiac disease compared to anti-tissue transglutaminase and IgA- endomysium antibodies.
Sayed SK; Imam HM; Mahran AM; Refaiy AM
Egypt J Immunol; 2012; 19(2):41-52. PubMed ID: 23885406
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to gliadin, endomysium, and tissue transglutaminase for the diagnosis of celiac disease.
Vitoria JC; Arrieta A; Arranz C; Ayesta A; Sojo A; Maruri N; García-Masdevall MD
J Pediatr Gastroenterol Nutr; 1999 Nov; 29(5):571-4. PubMed ID: 10554125
[TBL] [Abstract][Full Text] [Related]
11. Celiac disease-related antibodies in Italian children with epilepsy.
Giordano L; Valotti M; Bosetti A; Accorsi P; Caimi L; Imberti L
Pediatr Neurol; 2009 Jul; 41(1):34-6. PubMed ID: 19520271
[TBL] [Abstract][Full Text] [Related]
12. IgA anti-tissue transglutaminase as a diagnostic marker of gluten sensitive enteropathy.
Lock RJ; Pitcher MC; Unsworth DJ
J Clin Pathol; 1999 Apr; 52(4):274-7. PubMed ID: 10474519
[TBL] [Abstract][Full Text] [Related]
13. A novel method for detecting IgA endomysial antibodies by using human umbilical vein endothelial cells.
Castellino F; Scaglione N; Grosso SB; Sategna-Guidetti C
Eur J Gastroenterol Hepatol; 2000 Jan; 12(1):45-9. PubMed ID: 10656209
[TBL] [Abstract][Full Text] [Related]
14. Serologic markers of untreated celiac disease in Libyan children: antigliadin, antitransglutaminase, antiendomysial, and anticalreticulin antibodies.
Ashabani A; Errabtea H; Shapan A; Tuckova L; Tlaskalova-Hogenova H
J Pediatr Gastroenterol Nutr; 2001 Sep; 33(3):276-82. PubMed ID: 11593122
[TBL] [Abstract][Full Text] [Related]
15. Extension of the celiac intestinal antibody (CIA) pattern through eight antibody assessments in fecal supernatants from patients with celiac disease.
Di Tola M; Marino M; Casale R; Di Battista V; Borghini R; Picarelli A
Immunobiology; 2016 Jan; 221(1):63-9. PubMed ID: 26271834
[TBL] [Abstract][Full Text] [Related]
16. Application of Deamidated Gliadin Antibodies in the Follow-Up of Treated Celiac Disease.
de Chaisemartin L; Meatchi T; Malamut G; Fernani-Oukil F; Hosking F; Rault D; Bellery F; Cellier C; Dragon-Durey MA
PLoS One; 2015; 10(8):e0136745. PubMed ID: 26322980
[TBL] [Abstract][Full Text] [Related]
17. Antibody reactivity against human and guinea pig tissue transglutaminase in children with celiac disease.
Hansson T; Dahlbom I; Hall J; Holtz A; Elfman L; Dannaeus A; Klareskog L
J Pediatr Gastroenterol Nutr; 2000 Apr; 30(4):379-84. PubMed ID: 10776947
[TBL] [Abstract][Full Text] [Related]
18. IgA cross-reactivity between a nuclear autoantigen and wheat proteins suggests molecular mimicry as a possible pathomechanism in celiac disease.
Natter S; Granditsch G; Reichel GL; Baghestanian M; Valent P; Elfman L; Grönlund H; Kraft D; Valenta R
Eur J Immunol; 2001 Mar; 31(3):918-28. PubMed ID: 11241297
[TBL] [Abstract][Full Text] [Related]
19. Tissue transglutaminase antibody determination in celiac disease. Analysis of diagnostic specificity of anti-human IgA-type assays.
Földes-Papp Z; Demel U; Berry D; Domej W; Fuchs D; Tilz GP
J Immunoassay Immunochem; 2002; 23(2):211-27. PubMed ID: 12033644
[TBL] [Abstract][Full Text] [Related]
20. Deamidated gliadin peptides as targets for celiac disease-specific antibodies.
Mothes T
Adv Clin Chem; 2007; 44():35-63. PubMed ID: 17682339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
